ERBB2 and breast cancer: Genome-wide proteomics of breast cancer cell lines, including SKBR3, reported hBCATc to correlate with higher levels of epidermal growth factor receptor (EGFR) expression, which is upregulated in TNBC, but not in HER2-positive breast cancer [35].